膀胱内卡介苗治疗后的肺部疾病
Pulmonary disease following intravesical BCG treatment.
作者信息
Kesten S, Title L, Mullen B, Grossman R
机构信息
Mount Sinai Hospital, Toronto, Canada.
出版信息
Thorax. 1990 Sep;45(9):709-10. doi: 10.1136/thx.45.9.709.
Abstract
Bacillus Calmette-Guérin (BCG) is an attenuated strain of Mycobacterium bovis that has been used in the treatment of malignant disease for over 20 years and for the treatment of bladder cancer since 1976. Major complications of this treatment are infrequent. We report two cases of systemic illness with pulmonary manifestations after treatment with intravesical BCG.
摘要
卡介苗（BCG）是一种减毒牛分枝杆菌菌株，已用于恶性疾病治疗20多年，自1976年起用于膀胱癌治疗。这种治疗的主要并发症并不常见。我们报告了两例膀胱内注射卡介苗治疗后出现肺部表现的全身疾病病例。
Zotero 插件